StockData
West Pharmaceutical Services Inc logo

West Pharmaceutical Services Inc (WST) stock

WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3031% above fair value
$414.12−3.68 (-0.88%)

Close on Nov 17, 2026Market cap $28.85BP/E 46.5Yield 0.21%

West Pharmaceutical Services price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

West Pharmaceutical Services's price to sales ratio was 8.7× on Nov 11, 2026, against 6.6× a year earlier. Over the last 5 years it ranged from 5.2× to 13.0×, with a median of 7.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20268.7×+2.2
2025Dec 31, 20256.6×−1.7
2024Dec 31, 20248.3×−0.6
2023Dec 29, 20238.9×+2.9
2022Dec 30, 20226.0×−7.0
2021Dec 31, 202113.0×+2.7
2020Dec 31, 202010.3×+4.1
2019Dec 31, 20196.2×+2.0
2018Dec 31, 20184.2×−0.4
2017Dec 29, 20174.7×+0.5
2016Dec 30, 20164.2×+1.1
2015Dec 31, 20153.1×+0.4
2014Dec 31, 20142.7×+0.1
2013Dec 31, 20132.5×+0.9
2012Dec 31, 20121.6×+0.4
2011Dec 30, 20111.2×−0.2
2010Dec 31, 20101.3×−0.0
2009Dec 31, 20091.3×–

More West Pharmaceutical Services figures

See a number that looks wrong?